Are you interested in staying up-to-date with the latest guideline recommendations for biomarker identification and application in Non-Small Cell Lung Cancer (NSCLC)? Our interactive program is here to help! With this program, you'll be able to select personalized treatment pathways based on the tumor profile, while incorporating the latest scientific advances applicable to a broad range of patients with PD-L1–positive NSCLC. Get ready to make informed decisions about the best treatment options for NSCLC.

CME/CE Accreditation Information

Improving Management of Advanced Non-Melanoma Skin Cancer is a comprehensive, evidence-based curriculum about the challenges in identifying patients at high risk for mBCC and la/mCSCC, screening methods and staging of these patients, and the new and emerging therapies for patients with NMSC. By participating in the program, you will be better able to identify patients at high risk for NMSC, enhance your understanding of multiple models of screening and staging for NMSC in immunosuppressed and other patients at elevated risk and strengthen your shared decision-making skills when communicating with your patients.

CME/CE Accreditation Information

Osteoarthritis and Pain: Intensive Training in Pain Management is a comprehensive evidence-based presentation about the burden of osteoarthritis (OA) and OA pain, the challenges of current pharmacologic and nonpharmacologic strategies, and evidence about the role of nerve growth factor in mediating pain associated with OA. By participating in the program, health care providers will have an enhanced understanding of the physiology and burden of OA pain and about investigational agents that may be beneficial for people with OA pain who have not had satisfactory relief with other treatments.

CME/CE Accreditation Information